High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project
- Sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Study ID
- NCT06881979
- Status
- Recruiting
Conditions
- Amyotrophic Lateral Sclerosis
- Charcot-Marie-Tooth Disease
- Chronic Inflammatory Demyelinating Neuropathy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- High-tech rehabilitative treatment — DEVICEVirtual Reality (e.g., VRRS Evo): Provides an engaging and immersive environment for cognitive and motor exercises. Stabilometric Platform (e.g., Gea Master or Prokin Technobody): Used for balance and postural control training. Treadmill System (e.g., Walkerview Technobody): Used for aerobic exercises with gait analysis and feedback
- Rehabilitation — OTHERTraditional rehabilitative treatment
Study Details
The primary objective is to demonstrate, in a population of chronic neuromuscular disease the non-inferiority of a rehabilitation treatment integrated with robotic and/or technological devices compared to traditional rehabilitation treatment in the level of fatigue. The main question it aims to answer is: Are high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, not inferior to traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with chronic neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.
Key Dates
- First listed
- Mar 18, 2025
- Start date
- Apr 28, 2025
- Status verified
- Apr 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Robotic treatment groupIn this arm, patients will undergo in motor and cognitive exercise using the VR device (e.g., VRRS EVO), treatment with proprioceptive exercises on a platform (e.g., GEA MASTER or PROKIN Technobody) to enhance postural control, aerobic exercises on a robotic treadmill (e.g. Walkerview Technobody) and usual physiotherapy treatment, such as passive and active assisted exercises
- Other: Control groupThe patients will receive the traditional rehabilitative treatment according to the good clinical practice according to the Diagnostic, Therapeutic and Care Pathways of each center involved
Primary Outcome Measure
Change from baseline in Fatigue Severity Scale [ Time Frame: At day 0, at day 15, at day 30, at day 45, at day 60 ]
Central Contacts
- Christian Lunetta, MD+39 0250725266
Related Studies
- Clinical Research in ALS StudyRecruiting · University of Miami · Miami, Florida
- The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) StudyRecruiting · University of Miami · Miami, Florida
- BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With TetraplegiaRecruiting · Leigh R. Hochberg, MD, PhD. · Sacramento, California
- The National Amyotrophic Lateral Sclerosis RegistryRecruiting · Centers for Disease Control and Prevention · Atlanta, Georgia